JP Morgan Chase’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
JP Morgan Chase's RGEN Position: Q3 2026 in Review
JP Morgan Chase reduced its Repligen (RGEN) stake by 65% in Q3 2026, selling an estimated $45.6M and leaving 147,624 shares worth $29.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.
JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 46 quarters since. The position peaked at $98.2M in Q1 2021. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- JP Morgan Chase held 147,624 shares of Repligen worth $29.3M as of Q3 2026.
- JP Morgan Chase sold 280,146 Repligen shares in Q3 2026, an estimated $45.6M.
- Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1901 holding.
- JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 46 quarters since.
- JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
- 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.